EP1868577A4 - Lacidipine particles - Google Patents

Lacidipine particles

Info

Publication number: EP1868577A4
Authority: EP; European Patent Office
Prior art keywords: lacidipine; particles; lacidipine particles
Prior art date: 2005-04-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06749977A

Other languages

German (de)

French (fr)

Other versions

EP1868577A1 (en

Inventor

Venkataraman Sundaram

Manoj Ramesh Kharkar

Sharat Pandurang Narasapur

Surya Narayana Devarkonda

Suhas Lalitadas Jawlekar

Ravi Kumar Komareddy

Adolf Ceaser Goldwyn

Aniruddha Bhalachandra Pandit

Mamta Mishra

Arunava Ghosh

Gurvinder Singh

Vijay Dinanathji Nasare

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Inc

Original Assignee

Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-15

Filing date

2006-04-13

Publication date

2009-12-09

2006-04-13 Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd

2007-12-26 Publication of EP1868577A1 publication Critical patent/EP1868577A1/en

2009-12-09 Publication of EP1868577A4 publication Critical patent/EP1868577A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)

EP06749977A 2005-04-15 2006-04-13 Lacidipine particles Withdrawn EP1868577A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
IN432CH2005		2005-04-15
IN436CH2005		2005-04-15
US68466805P	2005-05-26	2005-05-26
US68469105P	2005-05-26	2005-05-26
PCT/US2006/013783 WO2006113309A1 (en)	2005-04-15	2006-04-13	Lacidipine particles

Publications (2)

Publication Number	Publication Date
EP1868577A1 EP1868577A1 (en)	2007-12-26
EP1868577A4 true EP1868577A4 (en)	2009-12-09

Family

ID=37115465

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06749977A Withdrawn EP1868577A4 (en)	2005-04-15	2006-04-13	Lacidipine particles

Country Status (2)

Country	Link
EP (1)	EP1868577A4 (en)
WO (1)	WO2006113309A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20140031557A1 (en) *	2011-04-18	2014-01-30	Hefeibeinie Medical Technology Company, Ltd.	Method for purification of calcium channel blockers of dihydorpyridine type and preparation of nanoparticles thereof
ITMI20131485A1 (en)	2012-09-10	2014-03-11	Rivopharm Sa	PHARMACEUTICAL COMPOSITION INCLUDING LACIPIDINE AND PREPARATION PROCESS

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5011848A (en) *	1984-08-22	1991-04-30	Glaxo, S.P.A.	1.4-dihydro pyridines
WO2003101624A1 (en) *	2002-05-28	2003-12-11	Battelle Memorial Institute	Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions
WO2004009057A1 (en) *	2002-07-18	2004-01-29	Astrazeneca Ab	Process for the preparation of crystalline nano-particle dispersions
WO2005014069A1 (en) *	2003-08-05	2005-02-17	Phoqus Pharmaceuticals Limited	Coating of surgical devices

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1244728B (en) *	1991-02-13	1994-08-08	Glaxo Spa	MEDICAL USE OF DIHYDROPYRIDINE DERIVATIVES
SE9501384D0 (en)	1995-04-13	1995-04-13	Astra Ab	Process for the preparation of respirable particles
GB9828721D0 (en)	1998-12-24	1999-02-17	Glaxo Group Ltd	Novel apparatus and process
GB0016040D0 (en)	2000-06-29	2000-08-23	Glaxo Group Ltd	Novel process for preparing crystalline particles
BR0209433A (en)	2001-05-05	2004-08-03	Accentus Plc	Method for crystallization and apparatus
US7931022B2 (en) *	2001-10-19	2011-04-26	Respirks, Inc.	Method and apparatus for dispensing inhalator medicament
GB0125604D0 (en)	2001-10-25	2001-12-19	Glaxo Group Ltd	Novel process
US20050095267A1 (en) *	2002-12-04	2005-05-05	Todd Campbell	Nanoparticle-based controlled release polymer coatings for medical implants

2006
- 2006-04-13 WO PCT/US2006/013783 patent/WO2006113309A1/en active Application Filing
- 2006-04-13 EP EP06749977A patent/EP1868577A4/en not_active Withdrawn

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5011848A (en) *	1984-08-22	1991-04-30	Glaxo, S.P.A.	1.4-dihydro pyridines
WO2003101624A1 (en) *	2002-05-28	2003-12-11	Battelle Memorial Institute	Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions
WO2004009057A1 (en) *	2002-07-18	2004-01-29	Astrazeneca Ab	Process for the preparation of crystalline nano-particle dispersions
WO2005014069A1 (en) *	2003-08-05	2005-02-17	Phoqus Pharmaceuticals Limited	Coating of surgical devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006113309A1 *

Also Published As

Publication number	Publication date
EP1868577A1 (en)	2007-12-26
WO2006113309A1 (en)	2006-10-26

Publication	Publication Date	Title
EP1973837A4 (en)	2012-11-07	Nanolipidic particles
GB2472541B (en)	2011-03-23	Nanoparticles
DE602006017073D1 (en)	2010-11-04	Aspartylproteasehemmer
PL1858635T3 (en)	2016-08-31	Microscapsule powder
GB0523969D0 (en)	2006-01-04	Inductivwe component
GB0608938D0 (en)	2006-06-14	Particulate material
GB0624980D0 (en)	2007-01-24	Modification
EP1862192A4 (en)	2010-12-22	Inhalator
DE602006021065D1 (en)	2011-05-12	Lithium-batteriepack
EP1953216A4 (en)	2009-11-11	Composite particle
EP1977992A4 (en)	2010-03-10	Nanosemiconductor particle
GB0526176D0 (en)	2006-02-01	Particle binding
EP2121726A4 (en)	2010-10-20	Protein particles
GB0610209D0 (en)	2006-07-05	Assay particles
EP1868577A4 (en)	2009-12-09	Lacidipine particles
EP1865780A4 (en)	2011-04-27	Mini-oven
GB0518478D0 (en)	2005-10-19	Particles
GB0511532D0 (en)	2005-07-13	Particulate materials
GB0507303D0 (en)	2005-05-18	Particles
GB0403262D0 (en)	2004-03-17	Particles
GB0625626D0 (en)	2007-01-31	Particles
GB0511123D0 (en)	2005-07-06	Substances
AU4036P (en)	2010-06-22	Dottie Calathea roseo-picta
GB0517240D0 (en)	2005-09-28	Chronorotron mk1-system and project
GB0517239D0 (en)	2005-09-28	Geogrotren-mk1-system and project

Legal Events

Date	Code	Title	Description
2007-11-23	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-12-26	17P	Request for examination filed	Effective date: 20071025
2007-12-26	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-05-14	RIN1	Information on inventor provided before grant (corrected)	Inventor name: NASARE, VIJAY DINANATHJI Inventor name: SINGH, GURVINDER Inventor name: GHOSH, ARUNAVA Inventor name: MISHRA, MAMTA Inventor name: PANDIT, ANIRUDDHA BHALACHANDRA Inventor name: GOLDWYN, ADOLF CEASER Inventor name: KOMAREDDY, RAVI KUMAR Inventor name: JAWLEKAR, SUHAS LALITADAS Inventor name: DEVARKONDA, SURYA NARAYANA Inventor name: NARASAPUR, SHARAT PANDURANGHOUSE NO. 8-7-193/47, " Inventor name: KHARKAR, MANOJ RAMESH Inventor name: SUNDARAM, VENKATARAMAN
2008-07-23	DAX	Request for extension of the european patent (deleted)
2009-12-09	A4	Supplementary search report drawn up and despatched	Effective date: 20091111
2009-12-09	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/455 20060101ALI20091105BHEP Ipc: A61K 31/435 20060101ALI20091105BHEP Ipc: A61K 9/20 20060101ALI20091105BHEP Ipc: A61K 9/16 20060101ALI20091105BHEP Ipc: A61K 9/14 20060101AFI20061110BHEP
2010-04-07	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: DR. REDDY'S LABORATORIES INC. Owner name: DR. REDDY'S LABORATORIES LTD.
2010-04-21	17Q	First examination report despatched	Effective date: 20100319
2011-05-19	TPAC	Observations filed by third parties	Free format text: ORIGINAL CODE: EPIDOSNTIPA
2011-11-02	17Q	First examination report despatched	Effective date: 20111004
2012-07-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2012-08-15	18D	Application deemed to be withdrawn	Effective date: 20120215